BlackRock Institutional Trust’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
Other funds holding IART
BFA
CIP
BlackRock Institutional Trust's IART Position: Q4 2016 in Review
BlackRock Institutional Trust increased its Integra LifeSciences (IART) stake by 6.1% in Q4 2016, buying an estimated $3.65M and bringing the position to 1,566,280 shares worth $67.2M. The position accounts for 0.01% of the portfolio, ranked #1154.
BlackRock Institutional Trust first reported a position in IART in Q2 2013 and has held it in 15 quarters since. 224 funds tracked by Wall St. Rank hold IART as of Q4 2016.
- BlackRock Institutional Trust held 1,566,280 shares of Integra LifeSciences worth $67.2M as of Q4 2016.
- BlackRock Institutional Trust bought 89,892 Integra LifeSciences shares in Q4 2016, an estimated $3.65M.
- Integra LifeSciences made up 0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #1154 holding.
- BlackRock Institutional Trust first reported a position in Integra LifeSciences in Q2 2013 and has held it in 15 quarters since.
- 224 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2016.
Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.